...
首页> 外文期刊>Saudi Pharmaceutical Journal >Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients
【24h】

Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients

机译:脂联素血清水平与2型糖尿病患者的胰岛素抵抗相关

获取原文

摘要

The adipose tissue is not only an inert storage depot for lipids, but also it secretes a variety of bioactive molecules, known as adipokines, which affect whole-body homeostasis. Adiponectin is the most abundant of these adipocytokines and is known to have a regulatory effect on the metabolism of glucose and lipid. The main objectives of this study were to evaluate the serum levels of adiponectin and to establish a correlation between adiponectin serum levels and the degree of insulin resistance in type 2 diabetic patients. Eighty participants were enrolled in this study; 61 type 2 diabetic patients and 19 apparently healthy subjects. Serum level of adiponectin was measured by enzyme-linked immunosorbent assay (ELISA) for each participant. Data collection sheet was filled with all required information for each participant. Adiponectin level in the diabetic patients (5.05+/-2.61@mg/ml) was lower than in non-diabetic healthy controls (5.71+/-2.35@mg/ml). When the results were compared according to gender, diabetic females showed significantly higher adiponectin levels (5.76+/-2.64@mg/ml) than diabetic males (4.366+/-2.43@mg/ml, P=0.035). In addition, female diabetic patients with abdominal obesity (waist circumference (WC)=88cm) had lower adiponectin levels (5.58+/-2.58@mg/ml) than diabetic females without abdominal obesity (6.96+/-3.12@mg/ml). The correlation analysis indicated that adiponectin had a significant positive correlation with age (r=-0.450, P0.001). In conclusion, female diabetic patients had a statistically significant higher adiponectin level than male diabetic patients which could indicate a gender effect. Adiponectin levels were inversely related to insulin resistance; as patients with abdominal obesity had lower serum levels of adiponectin.
机译:脂肪组织不仅是脂质的惰性储存库,而且还分泌多种生物活性分子,称为脂肪因子,可影响全身的体内平衡。脂联素是这些脂肪细胞因子中含量最多的,并且已知对葡萄糖和脂质的代谢具有调节作用。这项研究的主要目的是评估2型糖尿病患者的脂联素血清水平,并建立脂联素血清水平与胰岛素抵抗程度之间的相关性。这项研究招募了80名参与者; 61名2型糖尿病患者和19名显然健康的受试者。通过酶联免疫吸附测定(ELISA)测量每个参与者的血清脂联素水平。数据收集表中填写了每个参与者的所有必需信息。糖尿病患者的脂联素水平(5.05+/-2.61@mg/ml)低于非糖尿病健康对照者(5.71+/-2.35@mg/ml)。当按性别比较结果时,糖尿病女性的脂联素水平(5.76+/-2.64@mg/ml)显着高于糖尿病男性(4.366 +/- 2.43 @ mg / ml,P = 0.035)。此外,患有腹部肥胖(腰围(WC)> = 88cm)的女性糖尿病患者的脂联素水平(5.58+/-2.58@mg/ml)低于没有腹部肥胖的糖尿病女性(6.96+/-3.12@mg/ml) )。相关分析表明脂联素与年龄呈显着正相关(r = -0.450,P <0.001)。总之,女性糖尿病患者的脂联素水平在统计学上高于男性糖尿病患者,这可能表明存在性别差异。脂联素水平与胰岛素抵抗呈负相关。因为腹部肥胖患者的血清脂联素水平较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号